American Cancer Society http://www.cancer.org
National Cancer Institute http://www.cancer.gov
Canadian Cancer Society http://cancer.ca
Canadian Breast Cancer Foundation http://www.cbcf.org
Gianni L, Dafni U, Gelber RD, et al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Lancet Oncol . 2011;12(3):236-244,
HER2 inhibitors for breast cancer. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated December 17, 2012. Accessed December 21, 2012.
Herceptin. Daily Med website. Available at: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2. Updated October 2010. Accessed December 21, 2012.
Hortobagyi GN. Trastuzumab in the treatment of breast cancer.
N Engl J Med.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after Adjuvant Chemotherapy in HER2-positive Breast Cancer. N Engl J Med. 2005;353(16):1659-1672.
Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
N Engl J Med.
Slamon DJ, Leyland-Jones B, Shak S, et al. Concurrent administration of anti-HER2 monoclonal antibody and first-line chemotherapy for HER2-overexpressing metastatic breast cancer: A phase III, multinational, randomized, controlled trial.
N Engl J Med.
Smith I, Procter M, Gelber RD, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Trastuzumab. American Cancer Society website. Available at:
http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/trastuzumab. Updated November 3, 2010. Accessed December 21, 2012.
Trastuzumab. EBSCO DynaMed website. Available at:
. Updated September 10, 2012. Accessed December 21, 2012.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.